Australia markets closed

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.3700-0.0300 (-0.88%)
At close: 04:00PM EDT
3.3700 0.00 (0.00%)
After hours: 05:02PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
83,155
61,904
173,314
183,351
Other short-term investments
365,542
455,416
283,988
644,559
Total cash
448,697
517,320
457,302
827,910
Other current assets
10,418
11,504
14,021
-
Total current assets
459,115
528,824
471,323
845,130
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
214,265
233,316
204,381
173,043
Accumulated depreciation
-51,084
-36,885
-23,361
-12,908
Net property, plant and equipment
163,181
196,431
181,020
160,135
Equity and other investments
3,645
76,468
382,378
207,946
Other long-term assets
16,896
19,856
16,107
14,618
Total non-current assets
183,722
292,755
579,505
382,699
Total assets
642,837
821,579
1,050,828
1,227,829
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
5,897
13,890
10,255
10,390
Accrued liabilities
11,656
15,806
18,170
28,995
Deferred revenues
86
95
156
38,992
Other current liabilities
-
-
-
2,842
Total current liabilities
37,079
53,728
47,907
94,320
Non-current liabilities
Other long-term liabilities
5,179
5,847
7,792
3,083
Total non-current liabilities
93,525
100,969
77,721
53,892
Total liabilities
130,604
154,697
125,628
148,212
Stockholders' equity
Common stock
169
144
142
140
Retained earnings
-1,562,233
-1,234,968
-894,554
-646,343
Accumulated other comprehensive income
-955
-9,926
-2,567
268
Total stockholders' equity
512,233
666,882
925,200
1,079,617
Total liabilities and stockholders' equity
642,837
821,579
1,050,828
1,227,829